Atlas Trials

A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers

Clinical trial NCT03978403 · COMPLETED

Trial details

NCT number
NCT03978403
Sponsor
Zosano Pharma Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2019-05-29
Primary completion
2019-06-28
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.